Clinical Probiotics for Vaginal, Urogenital & Menopausal Wellness

The estrobolome is the collection of gut microbiome bacteria that possess beta-glucuronidase (GUS) enzyme activity, enabling them to deconjugate estrogen metabolites in the gut and allow those estrogens to be reabsorbed into systemic circulation. In practical terms, the composition and activity of the estrobolome directly influences circulating estrogen levels in the body.

For brands developing women’s health products, this mechanism is the scientific foundation behind a new generation of menopause and hormonal wellness formulations. Rather than targeting hormones directly, precision probiotics can be selected for their documented GUS enzyme activity, supporting estrogen recycling through the gut rather than through hormonal intervention. KABP® Menopause is built on exactly this mechanism, combining three clinically studied strains in a formulation with clinical evidence for maintaining normal serum estrogen levels in healthy menopausal women.

Kaneka Probiotics offers one of the most clinically substantiated women’s health probiotic portfolios available to brands, spanning menopause wellness, vaginal microbiota balance, vaginal restoration, and urogenital health — each supported by strain-specific, indication-targeted evidence.

Key formulations include:

• KABP^® Menopause — L. plantarum KABP^® 051, L. brevis KABP^® 052, P. acidilactici KABP^® 021 — Two clinical studies; clinically studied for maintaining normal serum estrogen levels in healthy menopausal women. Winner, NutraIngredients Awards 2025.
• KABP^® Vaginal Balance — L. gasseri KABP^®-064 — shown to colonize the vaginal tract during supplementation and support vaginal microbiota balance.
• KABP^® Vaginal Restore — L. plantarum KABP^® 061 — Two clinical studies; targeted vaginal microbiota balance via vaginal tablet delivery.
• KABP^® CysCare — L. plantarum KABP^® 062 and KABP^® 063 — One clinical study supporting urogenital microbiota balance.
• Unique IS2^® — Weizmannia (Bacillus) coagulans IS-2^® — supports a healthy vaginal microbiota alongside intestinal and bowel health.

Specific probiotic strains support vaginal microbiota balance by colonizing the vaginal tract, reinforcing the dominance of beneficial Lactobacillus species, and helping maintain the microbial stability of the vaginal ecosystem. The vaginal microbiota is a distinct and sensitive microbial community. Its balance can be affected by hormonal shifts, life stages, and other physiological changes across a woman’s life.

Strain selection is critical. Not all probiotic species colonize the vaginal environment effectively, and the mechanism of delivery (oral vs. vaginal) influences how and where a strain exerts its effects. KABP® Vaginal Balance (L. gasseri KABP®-064) has been shown to colonize the vaginal tract during the course of supplementation, directly supporting vaginal microbiota balance. KABP® Vaginal Restore (L. plantarum KABP® 061) is formulated as a vaginal tablet, delivering the strain directly to the site of action for targeted microbiota applications.

Probiotics support menopause wellness primarily through the estrobolome — by modulating the gut bacteria responsible for estrogen metabolism — as well as by supporting vaginal microbiota stability during a period when declining estrogen levels can alter both the gut and vaginal microbial ecosystems.

KABP^® Menopause is a three-strain formulation developed specifically for this application. Combining L. plantarum KABP^® 051, L. brevis KABP^® 052, and P. acidilactici KABP^® 021, it is clinically studied to help maintain normal serum estrogen levels in healthy menopausal women, with L. brevis KABP^® 052 selected specifically for its beta-glucuronidase activity within the estrobolome. The formulation won the Nutra Ingredients Awards 2025, reinforcing its standing as one of the most rigorously validated menopause probiotic solutions available to brands.